NurExone Biologic Inc.: NurExone Announces Completion of Securites for Debt Settlement

Calgary, Alberta--(Newsfile Corp. - December 7, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (formerly, EnerSpar Corp. or "EnerSpar") (the "Company" or "NurExone"), a biopharmaceutical company

Related Keywords

Israel ,Lior Shaltiel ,Company On ,Enerspar Corp ,Nurexone Biologic Inc ,Enerspar The Company Or Nurexone ,Alberta Newsfile Corp ,Israel Institute Of Technology ,Venture Exchange ,Regulation Services Provider ,Exone Biologic ,Reverse Takeover Transaction ,Exone Biologic Inc ,Israel Institute ,Executive Officer ,Nurexone ,Biologic ,Nnounces ,Completion ,Securites ,Debt ,Settlement ,